Hypidone Hydrochloride tablets

DRUG3 trials

Sponsors

Zhejiang Huahai Pharmaceutical Co., Ltd.

Conditions

Major Depressive Disorder

Phase 1

To Explore the Safety and Efficacy of Hypidone Hydrochloride Tablets in Treatment of Patients With MDD

CompletedNCT03404466

Zhejiang Huahai Pharmaceutical Co., Ltd.Major Depressive Disorder

Start: 2018-02-24End: 2018-07-17Updated: 2020-10-30

Tolerability and Pharmacokinetics of Hypidone Hydrochloride in Healthy Subjects

CompletedNCT04598607

Zhejiang Huahai Pharmaceutical Co., Ltd.Major Depressive Disorder

Start: 2020-10-30End: 2021-01-15Updated: 2021-08-25

Phase 2

Study to Explore the Effective Doses and to Assess the Safety and Efficacy of Hypidone Hydrochloride Tablets

CompletedNCT03739632

Zhejiang Huahai Pharmaceutical Co., Ltd.Major Depressive Disorder

Start: 2018-11-30End: 2019-12-23Updated: 2020-10-30